Introduction {#Sec1}
============

Kabuki syndrome (KS, OMIM\#147920) is a rare syndrome with multiple congenital anomalies. It was first reported by Japanese researchers Kuroki and Niikawa \[[@CR1], [@CR2]\]. KS is a heterogeneous condition, two causative genes having been identified so far. The causative gene of KS was identified in 2010 when Bögershausen et al. \[[@CR3]\] reported de novo heterozygous variants in *KMT2D* gene, which is located on chromosome 12q13. Later, in 2012, variants in the *KDM6A* gene, which is located on chromosome Xp11.23, were identified as another causative gene for KS \[[@CR4]\].

Consistent features of KS included distinctive facial dysmorphism (long palpebral fissures, depressed nasal tip and large ears), short stature, intellectual disability, skeletal abnormalities and dermatoglypic abnormalities. Other recurrent features such as congenital cardiac anomalies, ureter malformation and hip joint dislocation had been reported in non-Chinese KS patients \[[@CR5]\]. In addition, uncommon features had also been reported. Topcu et al. reported perisylvian cortical dysplasia in a KS patient from Turkey \[[@CR6]\]. However, there is little information about brain abnormalities in KS patients.

Herein, we analyzed 7 patients, and identified 7 deleterious *KMT2D/KDM6A* variants including 6 truncating and 1 missense variants. Of them, 5 variants were novel. To date, 40 sporadic Chinese KS patients had been reported \[[@CR7]--[@CR15]\]. We evaluated the phenotype spectra of all Chinese KS patients and paid particular attention to the brain abnormalities among a total of 47 unrelated Chinese KS patients.

Subjects and methods {#Sec2}
====================

Subjects {#Sec3}
--------

Seven patients with clinical presentation of Kabuki syndrome were enrolled from Fuzhou Children's Hospital of Fujian and Beijing Children's Hospital, China. This study was approved by the Ethics Committee of Fuzhou Children's Hospital of Fujian, and written informed consents were obtained from the participants' legal guardians.

Whole-exome sequencing and variants interpretation {#Sec4}
--------------------------------------------------

Genomic DNA was extracted from peripheral blood leukocytes of each patient. Blood samples from the parents were also collected if available. The whole-exome sequencing (WES) was performed at Shanghai Children's Medical Center and MyGenostics, Beijing, China. An adaptor-ligated library was prepared using SureSelect Human All Exon Kit (Agilent Technologies, Santa Clara, America) according to the manufacturer's protocol. Target regions were sequenced on an Illumina Hiseq X Ten System (Illumina, San Diego, America). Paired end reads were aligned to the GRCh37/hg19 human reference sequence. BAM files were generated by Picard and sequence variants were called by Genome Analysis Toolkit (GATK) Haplotype Caller.

Variants were annotated by TGex and putative pathogenic variants detected in the patients by WES were validated by Sanger sequencing. Variants were classified following the ACMG/AMP standards and guidelines \[[@CR16]\].

Results {#Sec5}
=======

Clinical manifestations of seven Chinese patients with KS {#Sec6}
---------------------------------------------------------

We enrolled 7 patients with clinical diagnosis of KS (three males and four females). The age of initial diagnosis ranged from 7 days to 3.2 years. These patients exhibited a diverse phenotype. The clinical features of the seven Chinese patients are listed in Table [1](#Tab1){ref-type="table"}. The main characteristics were as following: facial dysmorphism (*n* = 7), cardiac abnormalities (*n* = 6), intellectual disability (*n* = 5), short stature (*n* = 4), skeletal abnormalities (*n* = 3), hearing impairment (n = 3) and dermatoglypic abnormalities (*n* = 2). Table 1Phenotypic summary of Chinese KS patientsPatient1234567Literature (*N* = 40)Chinese cohort (*N* = 47)Non-Chinese cohort (*N* = 86) (Ref. [@CR17])GenderFemaleFemaleMaleFemaleMaleMaleFemaleAge of diagnosis1.3 yrs11 Months5 Months7d7 yrs2.6 Months3.2 yrsGrowth Short stature+------+++2357.4%57%Neurological abnormalities Intellectual disability+--+NA+++3280.4%90% Seizures--------------48.5%15% Cerebellar vermis dysplasia--------------12.1% Corpus callosum hypoplasia--------------12.1% Dany-Walker malformation--------------12.1% Thinning of pituitary--------+----02.1% Delay myelination of cerebral----+--------02.1% Hydrocephalus--------------12.1%Craniofacial features Microcephaly--++--------310.6%41% Micrognathia--------------36.3%39% High forehead and hairline+------------02.1% Low hairline+------------26.3% Hypertelorism----+----+--821.2% Epicanthus--------+----819.1% Long palpebral fissures--++------+1538.2%99% Strabismus--------------12.1%37% Eversion of lateral third of lower eyelids+--+--+--+1438.2%87% Long eyelashes+----------+923.9% Arched eyebrows+--------+--28.7% Sparse eyebrows--------++--1842.5% Depressed nasal tip++------++2970.2%80% Wide nasal bridge++------+--721.9% A displastic ear--+----------38.7% Large ears--+----++--2968.0%79% High-arched/cleft palate--++------+2457.4%66% Thin upper vermillion+------+--+210.6%76% Abnormal dentition--------------510.6%51%Congenital heart defect++++--++1442.6%42% Aortic coartation--+----------14.3% Atrial septal defect+--++--+--621.7% Ventricular septal defects+--++----+621.7% Patent ductus arteriosus------+--+--16.5% Patent foramen ovale++++----+521.7% Aortic arch dysplasia------+------02.2%Internal organ problem Feeding difficulties+------------38.5% Anal atresia----------+--38.5% Bilateral inguinal hernia--------------24.2% Splenomegaly----------+--14.2% Cryptorchidism--------------12.% Hearing impairment--++----+--1334.0%25% Otitis media----------+--1227.6% Cholesteatoma--------+----26.4% Cochlear dysplasia----------+--02.1% Renal/ureter malformation------+++--210.6%40%Musculoskeletal features Hip joint dislocation--------+--+923.4%26% Right diaphyseal femoral fracture------------+02.1% Fifth finger clinodactyly+------------2248.9%84% Absent palmer transverse crease----+--------512.7% Fingertip pads+------------2453.2%89%Endocrine Hypoglycemia--++--------28.5%7--8% Early breast development----------+14.2%28%

Pathogenic variants in *KMT2D* and *KDM6A* {#Sec7}
------------------------------------------

By WES, we identified six variants (c.3926delC/p.P1309Qfs\*21, c.5845delC/p.Q1949Sfs\*98, c.6595delT/p.Y2199Ifs\*65, c.12630delG/p.Q4210fs\*5, c.16294C \> T/p.R5432W and c.16442delG/p.C5481Lfs\*6) in exon 12, 27, 31, 39, 51 and 52 of *KMT2D* gene (NM_003482.3), respectively, and one variant (c.2668-2671del) in exon 18 of *KDM6A* gene (NM_021140.3). The variants identified (c.5845delC, c.2668-2671del and c.12630delG) in 3 patients were confirmed by Sanger sequencing, and they were absent from their parents. The other 4 patients' parental DNA were not available for genetic testing. Four variants (c.3926delC, c.5845delC, c.12630delG and c.16442delG in *KMT2D* gene, and the variant in *KDM6A* gene) were novel. Those 6 frameshift variants were predicted to lead to nonsense-mediated decay of mRNA. These null variants can all be classified as pathogenic according to the ACMG/AMP standards and guidelines (c.3926delC, c.5845delC, c.6595delT, c.12630delG, c.16442delG and c.2668-2671del). The remaining missense variant c.16294C \> T; p.R5432W in *KMT2D* gene has been previously reported \[[@CR17]\]. The variant c.16294C \> T; p.R5432W was predicted to be deleterious by multiple in silico software, including SIFT (damaging), PolyPhen-2 (probably damaging), MutationTaster (disease causing), PROVEAN (deleterious), and CADD (damaging). Therefore, it can be considered to be likely pathogenic.

Phenotypic spectrum of 47 Chinese KS patients {#Sec8}
---------------------------------------------

Forty Chinese patients had been previously reported with *KMT2D/KDM6A* mutations. With the new 7 patients adding, we summarized the phenotypic features of a total of 47 Chinese KS patients (Table [1](#Tab1){ref-type="table"}). The major clinical signs were as following: facial dysmorphisms (47/47; 100%), intellectual disability (36/45; 80%), short stature (27/47; 57.4%) patients, fingertip pads (25/47; 53.1%), finger clinodactyly (23/47; 48.9%), 5th finger clinodactyly (23/47; 48.9%), congenital cardiac anomalies (20/47; 42.5%) and hip joint dislocation (11/47; 23.4%). Additionally, brain imaging datasets were available for 17 patients and five patients (5/17, 29.4%) exhibited disparate brain anomalies.

Discussion {#Sec9}
==========

The genotypic spectrum of 47 Chinese KS patients (23 females, 24 males, 3 are sibs), including 42 *KMT2D* variants and 3 *KDM6A* variants were summarized (Table [2](#Tab2){ref-type="table"}). Of the 42 *KMT2D* variants, there are 1 splicing, 1 non-frameshift indel, 10 nonsense, 13 frameshift and 17 missense variants. All of the nonsense and frameshift variants were categorized as pathogenic because the protein structure was significantly altered. We used silico prediction models including PolyPhen-2, PROVEAN, MutationTaster to analyze the missense variants. Two missense variants (c.7130C \> T and c.11638C \> A) are predicted to be benign, neutral or polymorphism by at least two of the three silico prediction models. The pathogenicity of the two variants (c.7130C \> T and c.11638C \> A) was inconclusive and could potentially be non-pathogenic according ACMG/AMP standards and guidelines. The p.R5432W variant was most common, observed in 3 unrelated patients (P2, P28 and P46), which may be a hot spot for *KMT2D* gene variation in Chinese Patients. Thirty four *KMT2D* variants and 3 *KDM6A* variants were confirmed by Sanger sequencing. Of them, 2 variants (c.16273C \> A and c.7130 C \> T) in *KMT2D* gene were inherited from their respective biological father, and 1 variant (c.335-1G \> T) in *KDM6A* were inherited from mother, whereas the other 34 variants were de novo. Table 2Genotypic summary of Chinese KS patientsCase IDLiteratureGenes involveMutationPreticted protein changesType of mutationInheritanceExonPathogenic classification1This study*KMT2D*c.5845delCp.Q1949Sfs\*98Frameshift delDe novo27Pathogenic2*KMT2D*c.16294C \> Tp.R5432WMissenseNA51Likely Pathogenic3*KDM6A*c.2668-2671delp.N891Vfs\*27Frameshift delDe novo18Pathogenic4*KMT2D*c.6595delTp.Y2199Ifs\*65Frameshift delNA31Pathogenic5*KMT2D*c.16442delGp.C5481Lfs\*6Frameshift delNA52Pathogenic6*KMT2D*c.3926delCp.P1309Qfs\*21Frameshift delNA12Pathogenic7*KMT2D*c.12630delGp.Q4210fs\*5Frameshift delDe novo39Pathogenic8\[[@CR7]\] Liu S, et al. BMC Med Genet. 2015, 16:26.*KMT2D*c.12199C \> Tp.P4067SrMissenseDe novo39Likely Pathogenicc.16295G \> Ap.R5432QMissenseDe novo51Likely Pathogenic9*KMT2D*c.4664C \> Tp.S1555FMissenseDe novo17Likely Pathogenic10*KMT2D*c.8639 T \> Cp.L2880PMissenseDe novo34Likely Pathogenic11*KMT2D*c.3095delTp.L1032Rfs24XFrameshift delNA11Pathogenic12*KMT2D*c.96C \> Gp.D32EMissenseDe novo2Likely Pathogenic13*KMT2D*c.4395dupCp.K1466Qfs25XFrameshift delNA15Pathogenic14*KMT2D*c.11638C \> A^a^p.L3880 MMissenseNA39Uncertain significance*15KMT2D*c.4140 T \> Ap.C1370XNonsenseNA14Pathogenicc.11718-11723delGCAACANon-Frameshift indelNA39Likely Pathogenic16\[[@CR8]\] Yang P, et al. Am J Med Genet A. 2016, 170 (6): 1613--21.*KDM6A*exon1-2delFrameshift delDe novoPathogenic17\[[@CR9]\] Wu BB, et al. Chin J Evid Based Pediatr. 2017, 12 (2):135--9.*KMT2D*c.12697C \> Tp.Q4233XNonsenseDe novo39Pathogenicc.12696C \> Tp.Q4232HMissenseDe novo39Pathogenic18*KMT2D*c.3495delCp.P1165Lfs\*47Frameshift delDe novo11Pathogenic*19KMT2D*c.10881delTp.L3627Rfs\*31Frameshift delDe novo39Pathogenic*20KMT2D*c.16498C \> Tp.R5500WMissenseNA53Likely Pathogenic*21KMT2D*c.12560G \> Ap.G4187EMissenseNA39Likely Pathogenic*22KMT2D*c.16273G \> Ap.E5425KMissenseNA51Likely Pathogenic*23*\[[@CR10]\] JUN LU, et al. MOLECULAR MEDICINE REPORTS. 2016, 14: 3641--3645.*KMT2D*c.4485C \> Ap.Y1495SMissenseDe novo16Pathogenic*24*\[[@CR11]\] Chengqi Xin, BMC Medical Genetics. 2018, 19:31*KMT2D*c.5235delAp.A1746Lfs\*39Frameshift delDe novo22Pathogenic*25KMT2D*c.7048G \> Ap.Q2350\*Frameshift delDe novo31Pathogenic*26*\[[@CR12]\] Ju-Li Lin, et al. Clinical Genetics, 2015, 88 (3): 255--260.*KMT2D*c.12307C \> Tp.Q4013XNonsenseDe novo38Pathogenic*27KMT2D*c.3754C \> Tp.R1252XNonsenseDe novo11Pathogenic*28KMT2D*c.16294C \> Tp.R5432WNonsenseDe novo51Likely Pathogenic*29KMT2D*c.5993A \> Gp.Y1998CMissenseDe novo28LikelyPathogenic*30KMT2D*c.16273G \> Ap. E5425KMissense*Father*51Likely Pathogenic*31KMT2D*c.16273G \> Ap. E5425KMissense*Father*51Likely Pathogenic*32KMT2D*c.16273G \> Ap. E5425KMissense*Father*51Likely Pathogenic*33KMT2D*c.8743C \> Tp.R2915XNonsenseDe novo34Pathogenic*34KMT2D*c.5269C \> Tp.R1757XNonsenseDe novo22Pathogenic*35KMT2D*c.16273G \> Ap.E5425KMissenseDe novo51LikelyPathogenic*36KMT2D*c.7650-1delCTp.P2550Rfs2604XFrameshift delDe novo31Pathogenic*37KMT2D*c.16135C \> Tp.Q5379XNonsenseDe novo51Pathogenic*38KMT2D*c.15326G \> Tp.C5109FMissenseDe novo48Pathogenic*39KMT2D*c.16498C \> Tp.R5500WMissenseDe novo53Pathogenic*40*\[[@CR13]\] LI Jieling, ea. al. J Clin Pediatr. 2018, 1 (36): 53--56.*KMT2D*c.7130C \> T^a^p.P2377LMissenseFather31Uncertain significance*41KMT2D*IVS9 + 2 T \> GSplice mutationDe novoPathogenic*42*\[[@CR14]\] Wang Hongmei, et al. Chin J Pediatr. 2018, 56 (11): 846--849.*KMT2D*c.11770C \> Tp.Q3924XNonsenseDe novo39Pathogenic*43KMT2D*c.13033A \> Tp.K4345XNonsenseDe novo39Pathogenic*44KMT2D*c.1763C \> Gp.S588XNonsenseDe novo10Pathogenic*45KMT2D*c.5848delTp.S1950Pfs\*97FrameshiftDe novo27Pathogenic*46KMT2D*c.16294C \> Tp.R5432WMissenseDe novo51LikelyPathogenic*47*\[[@CR15]\] Guo Z,et al. BMC Med. Genet. 2018, 12 03;19 (1).*KDM6A*c.335-1G \> TSplice site mutation*mother*Likely Pathogenic^a^No sufficient evidence supporting it's pathogenicity \*Denotes a frameshift change as the first affected amino acid

A phenotypic comparison between the 47 Chinese patients and a cohort of 86 patients from other populations was showed in Table [1](#Tab1){ref-type="table"}. It was reported that the long palpebral fissures were observed in 99% of non-Chinese KS patients, and the eversion of lateral third of lower eyelids 87% \[[@CR17]\]. The Chinese patients showed a significantly lower frequency (38.2% for both features). While a lack of clinical acuity in recognizing these features by clinicians could account for some differences, we think it may more likely reflecting the ethnicity difference in feature presentations. Additionally, The Chinese patients had higher frequency of hearing impairment but lower frequency of microcephaly, micrognathia, strabismus, abnormal dentition, fifth finger clinodactyly and fingertip pads. The frequencies of other phenotypes including short stature, intellectual disability, cardiac defects, large eras, hypoglycemia and high-arched/cleft palate were consistent with previously reported \[[@CR17]\].

*KMT2D/KDM6A* affects genes and biological processes globally. The clinical consequence of *KMT2D/KDM6A* gene mutations also seems to have a global effect on development and growth, both craniofacial, cardiac, neural and musculoskeletal (presented with short stature) tissue \[[@CR18]\]. Across the board, the Chinese KS patients had typical facial features. These dysmorphic features included long palpebral fissures, depressed nasal tip and large ears (most prominent from the profile), similar to the KS patients from other ethnicities, indicating a consistent and highly penetrant facial dysphormic profile across populations.

Thirty-one Chinese patients presented with intellectual disability, most were mildly affected. Mehmet et al. \[[@CR19]\] reported one and Parisi et al. \[[@CR20]\] reported three KS patients with autism spectrum disorder, yet none of the Chinese KS patients exhibited autistic features or significant behavioral issues. Various structural brain anomalies had been infrequently described in KS patients. Topcu et al. reported perisylvian cortical dysplasia \[[@CR6]\]. Cedrik et al. reported two patients presented with holoprosencephaly \[[@CR21]\]. Furthermore, based on MRI, significantly decreased grey matter volume in the bilateral hippocampus and dentate gyrus have been described in KS patients \[[@CR22]\]. We found the brain abnormalities including thinning of pituitary and myelination of cerebral white matter in Chinese KS patients, which were not previously reported in KS patients. We also found that hydrocephalus, corpus callosum hypoplasia and Dandy-Walker malformation which had been reported previously both in Chinese patients and other populations \[[@CR7], [@CR15]\]. In addition, cerebellar vermis dysplasia was initially reported in Chinese patients \[[@CR11]\]. These observations suggested a strong association between various brain abnormalities and KS. Further study is needed to explore the clinical consequences of these brain abnormalities.

Conclusions {#Sec10}
===========

We described five novel variants that are causal for the seven KS Chinese patients, and confirmed that the Chinese KS presented with typical clinical phenotypes as previously reported in non-Chinese patients, but of variable feature prevalence. We also pointed out that brain structural abnormalities including thinning of pituitary and delay myelination of cerebral white matter may be part of KS phenotype that warrant further investigation.
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